ACIUAC Immune SAvs its industry peers
A metric-by-metric comparison of AC Immune SA against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACIUThis | $273M#6 | — | — | — | — | — | — | — | — | — | 7.8%#3 | — |
| ADTX | $7588#9 | 0.0x#1 | — | 2.4x#2 | -97.6%#5 | -6.8%#5 | -612542.2%#5 | — | — | — | -100.0%#5 | — |
| AAPG | $6.5B#3 | — | 179.1x#3 | 52.1x#4 | — | — | — | -153.5%#4 | — | — | -55.2%#4 | — |
| ABUS | $1.0B#4 | 6.4x#2 | 3.9x#1 | 71.1x#5 | 128.2%#2 | 52.1%#1 | -271.0%#2 | -12.9%#1 | — | — | 11.6%#2 | — |
| ABVX | $8.4B#2 | — | — | — | — | — | — | — | — | — | 24.1%#1 | — |
| ACUT | — | — | — | — | — | -16.7%#6 | — | — | — | — | — | — |
| ADAG | $176M#7 | — | 5.0x#2 | 23.0x#3 | 7332.8%#1 | 47.3%#2 | -279.5%#3 | -49.8%#2 | — | — | — | — |
| ADCT | $139M#8 | — | — | 1.7x#1 | 14.9%#3 | 9.6%#4 | -149.3%#1 | — | — | — | — | — |
| ADXN | $543M#5 | — | — | — | — | — | — | — | — | — | — | — |
| AKTX | $1.62T#1 | — | 86904.8x#4 | 4392758.3x#6 | -39.5%#4 | 12.6%#3 | -4695.9%#4 | -93.0%#3 | -155.6%#1 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice